FDA To Hold Meeting On Behind-the-Counter Drug Classification; Some Researchers Concerned About New FDA Center
Summaries of two recent developments related to FDA appear below.BTC classification: FDA next month plans to hold a meeting of stakeholders to consider the possibility of a behind-the-counter classification for medications, CongressDaily reports (Edney, CongressDaily, 10/15). [click link for full article]
Recent Comments